AzTrials
AzTrials

Cerebral Palsy Spastic DiplegiaNCT07534228

Comparative Effects of Play-Based Therapy and NDT in Diplegic CP

A study testing Group B Play-Based Therapy and Group A NDT in people with Cerebral Palsy Spastic Diplegia, run by University of Lahore at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

To compare the efficacy of play-based therapy versus NDT in improving fine motor skills in children with Spastic Diplegic Cerebral Palsy. Baseline Assessments (Pre-Intervention) To Establish baseline motor function, balance, and goals. Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Cerebral Palsy Spastic Diplegia
What is being tested?
Group B Play-Based Therapy and Group A NDT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 sitePakistan
Study dates
31 Aug 2025to 17 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Confirmed medical diagnosis of spastic diplegic cerebral palsy by a healthcare professional.
  • Children aged between 8 to 12 years old.
  • Documented difficulties in fine motor skills, assessed by a standardized motor skills evaluation tool.
  • Ability to understand and follow instructions, with or without assistance, to participate in the therapy sessions.
  • Written informed consent from parents or legal guardians, allowing the child to participate in the study.

Who cannot join

  • Presence of any other significant medical condition that might interfere
  • Diagnosis of other forms of cerebral palsy (e.g., hemiplegic, quadriplegic).
  • Severe cognitive impairments that would prevent understanding or participation in the therapy sessions.
  • Presence of uncontrolled medical conditions (e.g., severe epilepsy, cardiac conditions) that would pose a risk during physical activity.
  • Previous extensive therapy for fine motor skills in the past 6 months, which might influence the study outcomes.
  • Lack of compliance or cooperation from the child or parents/guardians during a preliminary assessment.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • University of Lahore teaching hospital

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Play-based Therapy Versus Neurodevelopmental Therapy in Children With Diplegic Cerebral Palsy

To compare the efficacy of play-based therapy versus NDT in improving fine motor skills in children with Spastic Diplegic Cerebral Palsy.

Baseline Assessments (Pre-Intervention) To Establish baseline motor function, balance, and goals.

Read more
  • Standardized Tools (Conducted in Week 1):
  • Peabody Developmental Motor Scales (PDMS-2): Evaluate gross and fine motor skills.
  • Modified Ashworth Scale: Assess spasticity in lower and upper limbs.
  • Pediatric Balance Scale (PBS): Measure static and dynamic balance.
  • Parent/Child Goal Setting: Identify individualized goals (e.g., stair climbing, dressing independence).
  1. Play-Based Therapy (PBT)
  • 5-Minute Warm-Up: Gentle play (e.g., rolling a ball, stretching with ribbons)
  • Building Blocks: Focus on fine motor control, bilateral coordination, and problem-solving.
  • Puzzles: Enhance spatial awareness, grip strength, and cognitive engagement.
  • Arts and Crafts: Promote hand-eye coordination (e.g., cutting, drawing) and creativity.
  • Frequency: 4 days a week, for 3 consecutive weeks
  • Intensity: Moderate effort; tasks tailored to the child's skill level (e.g., 5 piece puzzles progressing to 10-piece).
  • Time: 45-minute sessions (30 minutes active play, 10 minutes rest/reinforcement). 2. Neurodevelopmental Therapy (NDT)
  • 5-Minute Warm-Up: Light mobility exercises (e.g., Hand pumps, seated marching).
  • Resistance Bands: Strengthen upper limbs (e.g. Bicep curls, shoulder abduction, chest presses.).
  • Small Dumbbells: Improve upper body strength (1-2 lbs for shoulder/arm exercises).
  • Stress Ball Squeezes: Enhance grip strength and hand function (5-10 reps/session).
  • Frequency: 4 days a week, for 3 consecutive weeks
  • Intensity: Moderate resistance; emphasize alignment and controlled movement
  • Time: 40-minute sessions (30 minutes active exercise, 10 minutes rest/feedback). Outcome Measures
  • Peabody Developmental Motor Scales (PDMS-2): for evaluating fine motor skills.
  • Modified Ashworth Scale (MAS): To measure muscle spasticity (tone) in the limbs.
  • CHQ: To measure health-related quality of life
Read the detailed description

To compare the efficacy of play-based therapy versus NDT in improving fine motor skills in children with Spastic Diplegic Cerebral Palsy.

Inclusion Criteria

  • Confirmed medical diagnosis of spastic diplegic cerebral palsy by a healthcare professional.
  • Children aged between 8 to 12 years old (Raipure, Kovela, \& Harjpal, 2023).
  • Documented difficulties in fine motor skills, assessed by a standardized motor skills evaluation tool.
  • Ability to understand and follow instructions, with or without assistance, to participate in the therapy sessions.
  • Written informed consent from parents or legal guardians, allowing the child to participate in the study. Exclusion Criteria
  • Presence of any other significant medical condition that might interfere
  • Diagnosis of other forms of cerebral palsy (e.g., hemiplegic, quadriplegic).(Raipure et al., 2023).
  • Severe cognitive impairments that would prevent understanding or participation in the therapy sessions.
  • Presence of uncontrolled medical conditions (e.g., severe epilepsy, cardiac conditions) that would pose a risk during physical activity.
  • Previous extensive therapy for fine motor skills in the past 6 months, which might influence the study outcomes.
  • Lack of compliance or cooperation from the child or parents/guardians during a preliminary assessment.(Raipure et al., 2023).

All participants will be given the intervention for 45 minutes, 4 days a week, for 3 consecutive weeks.

Being tested
Group B Play-Based Therapy, Group A NDT
Keywords
Neurodevelopmental Therapy, Play Based Therapy, Spastic diplegic cerebral palsy, Fine motor skills, Spasticity, Quality of life
Medical subject headings
Cerebral Palsy, Muscle Spasticity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group B Play-Based TherapyOther

    Building blocks, puzzles, Arts and crafts. frequency 4 days a week for 12 consecutive weeks time duration is 45 minutes per session

  • Group A NDTOther

    Resistance Bands, Small Dumbbells, Stress Ball Squeezes frequency is 4 days a week for 12 consecutive weeks.

    time: 40 minutes per session

Study groups in NCT07534228
Study groupRoleWhat they receive
Group A NDTExperimental5-Minute Warm-Up: Light mobility exercises (e.g., Hand pumps, seated marching) * Resistance Bands: Strengthen upper limbs (e.g. Bicep curls, shoulder abduction, chest presses.). * Small Dumbbells: Improve upper body strength (1-2 lbs for shoulder/arm exercises). * Stress Ball Squeezes: Enhance grip strength and hand function (5-10 reps/session). * Frequency: 4 days a week, for 3 consecutive weeks * Intensity: Moderate resistance; emphasize alignment and controlled movement * Time: 40-minute sessions (30 minutes active exercise, 10 minutes rest/feedback).
Receives: Other: Group A NDT
Group B Play-Based TherapyExperimental5-Minute Warm-Up: Gentle play (e.g., rolling a ball, stretching with ribbons) * Building Blocks: Focus on fine motor control, bilateral coordination, and problem-solving. * Puzzles: Enhance spatial awareness, grip strength, and cognitive engagement. * Arts and Crafts: Promote hand-eye coordination (e.g., cutting, drawing) and creativity. * Frequency: 4 days a week, for 3 consecutive weeks * Intensity: Moderate effort; tasks tailored to the child's skill level (e.g., 5 piece puzzles progressing to 10-piece). * Time: 45-minute sessions (30 minutes active play, 10 minutes rest/reinforcement).
Receives: Other: Group B Play-Based Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peabody Developmental Motor Scales (PDMS-2)

    for evaluating fine motor skills.

    Measured: from enrollment to the end of treatment at 12 weeks

  2. Modified Ashworth Scale (MAS)

    To measure muscle spasticity (tone) in the limbs.

    Measured: at the time of enrollment and at the end of 12 week

Secondary outcomes (1)
  1. CHQ

    To measure health-related quality of life

    Measured: at the time of enrollment then 8 week and then 12 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2026
  2. Study start31 Aug 2025
  3. Primary completion15 Apr 2026 (estimated)
  4. Study completion17 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07534228
Sponsor's protocol ID
UOL/IREB/25/09/0033
Status last verified
Nov 2025
First submitted
9 Apr 2026
Last updated
16 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group B Play-Based Therapy and Group A NDT in people with Cerebral Palsy Spastic Diplegia, run by University of Lahore at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peabody Developmental Motor Scales (PDMS-2) (time frame: from enrollment to the end of treatment at 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in